New inhibitor of acetylcholinesterase with preferential activity at nicotinic sites.
D000109:Acetylcholine; D000818:Animals; D001665:Binding Sites; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases; D003510:Cyclohexanes / Q000494:pharmacology*; D004491:Edrophonium / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D051381:Rats; D014403:Tubocurarine / Q000037:antagonists & inhibitors
D002800:Cholinesterase Inhibitors; D003510:Cyclohexanes; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D004491:Edrophonium; D002802:Cholinesterases; D000109:Acetylcholine; D014403:Tubocurarine